source
- Nourish secures $100M funding, valuation climbs to $1.75BNourish, a New York-based telehealth platform that connects patients with nutritionists, announced a fresh financing round. The round raised $100 million and lifted the company's valuation to abou…
- Paragon Therapeutics moves migraine-focused Mentari Therapeutics public via reverse mergerParagon Therapeutics, a hub-and-spoke biotech company, is taking its migraine drug subsidiary Mentari Therapeutics public through a reverse merger. The approach follows Paragon's prior use of reve…